How microdosing differs from standard GLP-1 therapy Standard semaglutide dosing for obesity targets sustained appetite suppression and metabolic rate changes
Studies recorded measurable decreases in specific inflammatory markers after therapy, indicating the improvements extended beyond subjective perception to actual biological changes
Its a gentle, science-backed approach that works with your body, not against it
International Journal of Molecular Sciences, 2025 DOI: 10.3390/ijms262411774 #MultipleSclerosis #Neuroimmunology #Biomarkers #OCT #DisabilityProgression #ClinicalResearch #Neurology To view or add a comment, sign in Exploring extracellular vesicles as diagnostic tools in gutbrain axis disorders: in this concise review article, Patricia Maral da Costa, Reinaldo Barreto Ori at Federal University of Ceara and collaborators integrated microbial- and brain-derived extracellular vesicles within the framework of gutbrain axis disorders and proposed three translational diagnostic niches: microbial EVs as systemic indicators of dysbiosis and immune activation, brain-derived EVs as liquid biopsies of central nervous system pathology, and engineered or technologically captured EVs as platforms for point-of-care testing
I had heard of peptides but hadnt done a deep dive into the research
Global, regional and national prevalence of overweight and obesity in children and adults 1980-2013: a systematic analysis